Distance Learning / Grand Rounds Recordings

Chronic Pain

CME Online Activities
Chronic Pain Slide Library


  

CME Information

Activity Title Addressing Regional Needs in the Management of Chronic Pain: A Focus on Opioid Misuse, Abuse, and Diversion
Topic Chronic pain
Target Audience Health care professionals such as primary care, pharmacy, or other clinicians who have a direct role in the management of chronic pain
Accreditation Type CME
Release Date May 2010
Expiration Date May 31, 2011
Estimated Time to Complete Activity 60 minutes

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

  • Identify the negative impact of chronic pain on health and quality of life, current methods to assess pain levels, appropriate use of opioid medications, and documentation required for compliance with regulatory policies
  • Integrate appropriate risk assessment strategies for patient abuse, misuse, and diversion among opioid therapies into an overall management approach for chronic pain
  • Describe the specific elements of new abuse deterrent technologies associated with opioid therapy and assess their implications for clinical practice


FACULTY - CONTENT CREATORS

Perry G. Fine, MD
Professor, Department of Anesthesiology
Pain Research Center
University of Utah School of Medicine
Salt Lake City, Utah


Scott M. Fishman, MD
Chief, Division of Pain Medicine
Professor of Anesthesiology and Pain Medicine
University of California, Davis
Davis, California


Lynn R. Webster, MD, FACPM, FASAM
Medical Director, Lifetree Clinical Research and Pain Clinic
Chief of Anesthesiology
Health South Salt Lake Surgical Center
Salt Lake City, Utah


ACTIVITY FACULTY

Howard S. Smith, MD, FACP, FAAPM, FACNP
Associate Professor
Departments of Anesthesiology, Medicine, and Physical Medicine & Rehabilitation
Academic Director of Pain Management
Department of Anesthesiology
Albany Medical College
Albany, New York


METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME information.
  3. Complete the CME activity
  4. Complete the CME evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  5. Your CME certificate will be emailed to you within 4 weeks.

      6. CLICK HERE TO VIEW TECHNICAL REQUIREMENTS


SPONSOR

This activity is sponsored by The France Foundation.


TARGET AUDIENCE

Health care professionals such as primary care, pharmacy, or other clinicians who have a direct role in the management of chronic pain.


STATEMENT OF NEED

This activity has been planned in accordance with the need to provide education surrounding advancements in pain management that will enable clinicians to thoroughly and appropriately assess all patients who require pain control, be proactive in educating patients, set realistic goals, and continually monitor clinical updates and improvements.


ACCREDITATION STATEMENT

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


CREDIT DESIGNATION

Physicians
The France Foundation designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.


DISCLOSURE

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all conflicts of interest prior to the release of this activity.


Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.


Faculty Disclosures - Content Creators

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

  • Dr. Perry G. Fine serves as consultant for Cephalon, King Pharmaceuticals, Neuroadjuvants, and OrthoMcNeil/Pricara. He has received honorarium from Forest and acts as medical expert on behalf of Janssen & Alza.
  • Dr. Scott M. Fishman has received grants/research support and has served as consultant and speakers bureaus for Elan Company, Endo Pharmaceuticals, Janssen Medical Affairs, LLC, Merck & Company, Inc., Pfizer, Inc., and Purdue Pharma, LP. He as also served as consultant for Cephalon, Inc., and Eli Lilly and Company.
  • Dr. Lynn R. Webster has received honoraria from Ameritox, AstraZeneca, Boston Scientific, Cephalon, Elan, King Pharmaceuticals, Medtronic, Nektar, Neurogex, Neuromed, Nevro, Purdue, and Wyeth. He has received research support from Allergan, Boston Scientific, Cephalon, Forest, Hisamitsu, Hoffman, King Pharmaceuticals, Lifetree Clinical Research, Medtronic, Nektar, NeurAxon, NeurogesX, Pfizer, Regeneron, and Wyeth.


Faculty Disclosure - Activity Creator

The following faculty have indicated they have relationships with industry to disclose relative to the content of this CME activity:

  • Dr. Howard Smith has received honoraria from Forest Laboratories.


UNAPPROVED USE DISCLOSURE

The France Foundation requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant from King Pharmaceuticals.


DISCLAIMER

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and King Pharmaceuticals assume no liability for the information herein.


COPYRIGHT INFORMATION

Copyright © 2010 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


PRIVACY POLICY

The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.


CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.

To apply for credit, Click here >>

  

Privacy Policy   Terms of Use   Contact Us